Rare cancer drugs budget underspent by nearly half

By Simon Lewis2011-06-16T06:42:00

Only 56 per cent of the money allocated for cancer drugs normally unavailable on the NHS was spent in the first six months of a high profile fund, a report has found.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
10 expert briefings every fortnight (Premium only)

to HSJ

Already a subscriber? Sign into your account here